Enhancement balloon vaginoplasty for treatment of blind vagina due to androgen insensitivity syndrome.
OBJECTIVE
To evaluate the safety and feasibility of enhancement balloon vaginoplasty (EBV) in cases with blind vagina due to androgen insensitivity syndrome.


METHODS
Case series with description of the technique.


METHODS
Women's Health Center, Assiut University, and Sohage Teaching Hospital, Sohage University.


METHODS
Three X,Y females (two cases presenting with apareunia and the third presenting with severe dyspareunia).


METHODS
Laparoscopy-assisted EBV.


METHODS
Operative time, complications, depth and width of neovagina, and functional status.


RESULTS
Our cases were currently married phenotypical females and had 46,X,Y karyotypes. They had well developed secondary sexual characters, but they presented with failure of intravaginal intercourse. EBV was performed successfully for three X,Y females. The total operative time was 38-45 minutes. No operative complications were reported, and there were no reported postoperative complications as a result of moving the direction of traction. The resultant neovagina's depths were 10, 11, and 12 cm, respectively. Sexual intercourse was set off on the day of discharge. Penetration and satisfaction scores increased up to 90 points for both partners.


CONCLUSIONS
It was feasible and safe to move centrally the direction of traction and to move the point of catheter exit up with apparently better outcomes than conventional balloon vaginoplasty for treatment of blind vagina due to androgen insensitivity syndrome.
Women's Health University Center, Department of Obstetrics and Gynecology, Faculty of Medicine, Assiut University, Assiut, Egypt. ali_elsaman@yahoo.com
Ali M
AM
El Saman
Alaa M
AM
Ismael
Mahmoud S
MS
Zakherah
Ahmed
A
Nasr
Reda M
RM
Tawfik
Mohamed A
MA
Bedaiwy
D000328:Adult; D013734:Androgen-Insensitivity Syndrome / Q000150:complications / Q000473:pathology / Q000628:therapy*; D002404:Catheterization / Q000009:adverse effects / Q000379:methods*; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D010535:Laparoscopy / Q000009:adverse effects / Q000379:methods; D008297:Male; D008954:Models, Biological; D009929:Organ Size; D014621:Vagina / Q000002:abnormalities* / Q000473:pathology; D055815:Young Adult